These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32964987)

  • 1. Extracellular vesicles and diabetic kidney disease: a systematic review.
    Tao QR; Wang LZ; Tu C
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8978-8987. PubMed ID: 32964987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles as signaling mediators in type 2 diabetes mellitus.
    Noren Hooten N; Evans MK
    Am J Physiol Cell Physiol; 2020 Jun; 318(6):C1189-C1199. PubMed ID: 32348178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of the efficacy and signaling pathways activated by stem cell-derived extracellular vesicles in diabetic kidney disease.
    Lin Y; Yang Q; Wang J; Chen X; Liu Y; Zhou T
    Front Endocrinol (Lausanne); 2022; 13():962635. PubMed ID: 35966088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
    Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic Nephropathy: Perspective on Extracellular Vesicles.
    Lu Y; Liu D; Feng Q; Liu Z
    Front Immunol; 2020; 11():943. PubMed ID: 32582146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and Management of Type 2 Diabetic Kidney Disease.
    Doshi SM; Friedman AN
    Clin J Am Soc Nephrol; 2017 Aug; 12(8):1366-1373. PubMed ID: 28280116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary Extracellular Vesicle: A Potential Source of Early Diagnostic and Therapeutic Biomarker in Diabetic Kidney Disease.
    Xu WC; Qian G; Liu AQ; Li YQ; Zou HQ
    Chin Med J (Engl); 2018 Jun; 131(11):1357-1364. PubMed ID: 29786051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel biomarkers of diabetic kidney disease: current status and potential clinical application.
    Barutta F; Bellini S; Canepa S; Durazzo M; Gruden G
    Acta Diabetol; 2021 Jul; 58(7):819-830. PubMed ID: 33528734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles metabolic changes reveals plasma signature in stage-dependent diabetic kidney disease.
    Pan Y; Yang H; Chen T; Jin J; Ruan L; Hu L; Chen L
    Ren Fail; 2022 Dec; 44(1):1840-1849. PubMed ID: 36368309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic Nephropathy: An Overview.
    Sagoo MK; Gnudi L
    Methods Mol Biol; 2020; 2067():3-7. PubMed ID: 31701441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
    Pugliese G; Penno G; Natali A; Barutta F; Di Paolo S; Reboldi G; Gesualdo L; De Nicola L;
    Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1127-1150. PubMed ID: 31586514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of inflammation in diabetic kidney disease.
    Jung SW; Moon JY
    Korean J Intern Med; 2021 Jul; 36(4):753-766. PubMed ID: 34237822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetes treatment in patients with chronic kidney disease].
    Süfke S; Steinhoff J; Schütt M
    Dtsch Med Wochenschr; 2013 May; 138(21):1109-18; quiz 1119-22. PubMed ID: 23677506
    [No Abstract]   [Full Text] [Related]  

  • 14. Extracellular Vesicles and Their Role in Urologic Malignancies.
    Junker K; Heinzelmann J; Beckham C; Ochiya T; Jenster G
    Eur Urol; 2016 Aug; 70(2):323-31. PubMed ID: 26924769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotten to the Cortex: Ceramide-Mediated Lipotoxicity in Diabetic Kidney Disease.
    Nicholson RJ; Pezzolesi MG; Summers SA
    Front Endocrinol (Lausanne); 2020; 11():622692. PubMed ID: 33584550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SGLT2 Inhibition for the Prevention and Treatment of Diabetic Kidney Disease: A Review.
    Alicic RZ; Johnson EJ; Tuttle KR
    Am J Kidney Dis; 2018 Aug; 72(2):267-277. PubMed ID: 29866460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic kidney disease: a report from an ADA Consensus Conference.
    Tuttle KR; Bakris GL; Bilous RW; Chiang JL; de Boer IH; Goldstein-Fuchs J; Hirsch IB; Kalantar-Zadeh K; Narva AS; Navaneethan SD; Neumiller JJ; Patel UD; Ratner RE; Whaley-Connell AT; Molitch ME
    Am J Kidney Dis; 2014 Oct; 64(4):510-33. PubMed ID: 25257325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicle-derived AEBP1 mRNA as a novel candidate biomarker for diabetic kidney disease.
    Tao Y; Wei X; Yue Y; Wang J; Li J; Shen L; Lu G; He Y; Zhao S; Zhao F; Weng Z; Shen X; Zhou L
    J Transl Med; 2021 Jul; 19(1):326. PubMed ID: 34332599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes-related end-stage renal disease in Austria 1965-2013.
    Prischl FC; Auinger M; Säemann M; Mayer G; Rosenkranz AR; Wallner M; Kramar R;
    Nephrol Dial Transplant; 2015 Nov; 30(11):1920-7. PubMed ID: 25977308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease.
    Guo J; Liu Z; Gong R
    Clin Sci (Lond); 2019 Jun; 133(12):1321-1339. PubMed ID: 31221822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.